Novavax, Inc. (NVAX) Reports In-Line Q1 EPS, Misses Revenue Expectations
Tweet
Share
E-mailGet Alerts NVAX Hot Sheet
Price: $9.42 --0%
Revenue Growth %: -78.2%
Financial Fact:
Revenue: 102K
Today's EPS Names:
CRMT, FOMI, FLES, More
Revenue Growth %: -78.2%
Financial Fact:
Revenue: 102K
Today's EPS Names:
CRMT, FOMI, FLES, More
Join SI Premium – FREE
Novavax, Inc. (NASDAQ: NVAX) reported Q1 EPS of ($0.07), in-line with the analyst estimate of ($0.07). Revenue for the quarter came in at $834 thousand versus the consensus estimate of $2.29 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Constellation Brands (STZ) Tops Q1 EPS by 18c
- Apogee Enterprises (APOG) Tops Q1 EPS by 16c, Beats on Revenue; Offers FY27 Guidance
- BlackBerry (BB) Tops Q1 EPS by 1c, Offers Guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
